Skip Navigation LinksHome > December 2013 - Volume 56 - Issue 4 > Osteoporosis: What’s New and on the Horizon
Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e3182a9ece0
Osteoporosis: Diagnosis and Management

Osteoporosis: What’s New and on the Horizon

SILVA, BARBARA C. MD, PhD; COSTA, ALINE G. MD; CUSANO, NATALIE E. MD; BILEZIKIAN, JOHN P. MD

Collapse Box

Abstract

In this review, we consider new concepts in the assessment of fracture risk and pharmacologic therapy for osteoporosis. We discuss trabecular bone score, a new imaging technology that adds information that cannot be obtained by only measuring bone mineral density by dual-energy x-ray absorptiometry. We also discuss innovations in antiresorptive, osteoanabolic, and combination therapy; and newer therapeutic classes, including cathepsin K inhibitors and antisclerostin antibodies. We do not cover agents that have not yet been studied in human clinical trials or that are no longer under active investigation.

© 2013 by Lippincott Williams & Wilkins.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.